Fingerprint
Dive into the research topics of 'Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates
Phillip R. Pittman, Sarah L. Norris, Elizabeth S. Brown, Manmohan V. Ranadive, Barbara A. Schibly, George E. Bettinger, Nandadeva Lokugamage, Lawrence Korman, John C. Morrill, Clarence J. Peters
Research output: Contribution to journal › Article › peer-review
25
Scopus
citations